trending Market Intelligence /marketintelligence/en/news-insights/trending/h924gnapp20rl-9uiye91q2 content esgSubNav
In This List

Shandong Xinhua Pharmaceutical adds independent nonexecutive director

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Shandong Xinhua Pharmaceutical adds independent nonexecutive director

Shandong Xinhua Pharmaceutical Co. Ltd. shareholders elected Lo Wah Wai as an independent nonexecutive director at their annual general meeting.

Lo is a director at BMI Consultants Ltd., independent nonexecutive director at Chongqing Machinery & Electric Co. Ltd. and Tenfu (Cayman) Holdings Co. Ltd., as well as outside director at Fasteps Co. Ltd.

He succeeds Chan Chung Kik, who resigned to focus on his other business commitments.

China-based Shandong Xinhua Pharmaceutical sells bulk pharmaceuticals, preparations and chemical products.